Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines.
Karishma DhuriSai Pallavi PradeepJason ShiEleni AnastasiadouFrank J SlackAnisha GuptaXiao-Bo ZhongRaman BahalPublished in: Pharmaceutical research (2022)
This project demonstrated that targeting miRNA-155 and miR-21 simultaneously using nanotechnology and a diverse class of antisense oligomers can be used as an effective approach for lymphoma therapy.